vs
Arcutis Biotherapeutics, Inc.（ARQT）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是Arcutis Biotherapeutics, Inc.的1.2倍（$151.1M vs $129.5M），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs 3.6%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs 5.1%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
ARQT vs RGR — 直观对比
营收规模更大
RGR
是对方的1.2倍
$129.5M
营收增速更快
ARQT
高出77.9%
3.6%
两年增速更快
ARQT
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $151.1M |
| 净利润 | $17.4M | — |
| 毛利率 | 91.0% | 17.8% |
| 营业利润率 | 14.2% | 2.3% |
| 净利率 | 13.4% | — |
| 营收同比 | 81.5% | 3.6% |
| 净利润同比 | 261.2% | — |
| 每股收益（稀释后） | $0.14 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARQTRGR
| Q4 25 | $129.5M | $151.1M | ||
| Q3 25 | $99.2M | $126.8M | ||
| Q2 25 | $81.5M | $132.5M | ||
| Q1 25 | $65.8M | $135.7M | ||
| Q4 24 | $71.4M | $145.8M | ||
| Q3 24 | $44.8M | $122.3M | ||
| Q2 24 | $30.9M | $130.8M | ||
| Q1 24 | $49.6M | $136.8M |
净利润ARQTRGR
| Q4 25 | $17.4M | — | ||
| Q3 25 | $7.4M | $1.6M | ||
| Q2 25 | $-15.9M | $-17.2M | ||
| Q1 25 | $-25.1M | $7.8M | ||
| Q4 24 | $-10.8M | — | ||
| Q3 24 | $-41.5M | $4.7M | ||
| Q2 24 | $-52.3M | $8.3M | ||
| Q1 24 | $-35.4M | $7.1M |
毛利率ARQTRGR
| Q4 25 | 91.0% | 17.8% | ||
| Q3 25 | 91.2% | 15.1% | ||
| Q2 25 | 90.8% | 3.9% | ||
| Q1 25 | 86.6% | 22.0% | ||
| Q4 24 | 90.3% | 22.8% | ||
| Q3 24 | 87.7% | 18.5% | ||
| Q2 24 | 88.8% | 22.3% | ||
| Q1 24 | 93.4% | 21.5% |
营业利润率ARQTRGR
| Q4 25 | 14.2% | 2.3% | ||
| Q3 25 | 8.6% | -2.7% | ||
| Q2 25 | -17.9% | -15.6% | ||
| Q1 25 | -37.3% | 6.2% | ||
| Q4 24 | -10.7% | 7.8% | ||
| Q3 24 | -87.3% | 3.1% | ||
| Q2 24 | -162.3% | 6.9% | ||
| Q1 24 | -63.8% | 5.5% |
净利率ARQTRGR
| Q4 25 | 13.4% | — | ||
| Q3 25 | 7.5% | 1.2% | ||
| Q2 25 | -19.5% | -13.0% | ||
| Q1 25 | -38.1% | 5.7% | ||
| Q4 24 | -15.1% | — | ||
| Q3 24 | -92.8% | 3.9% | ||
| Q2 24 | -169.6% | 6.3% | ||
| Q1 24 | -71.4% | 5.2% |
每股收益（稀释后）ARQTRGR
| Q4 25 | $0.14 | $0.22 | ||
| Q3 25 | $0.06 | $0.10 | ||
| Q2 25 | $-0.13 | $-1.05 | ||
| Q1 25 | $-0.20 | $0.46 | ||
| Q4 24 | $-0.09 | $0.62 | ||
| Q3 24 | $-0.33 | $0.28 | ||
| Q2 24 | $-0.42 | $0.47 | ||
| Q1 24 | $-0.32 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $92.5M |
| 总债务越低越好 | $109.0M | — |
| 股东权益账面价值 | $189.5M | $283.8M |
| 总资产 | $433.0M | $342.0M |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
现金及短期投资ARQTRGR
| Q4 25 | $42.9M | $92.5M | ||
| Q3 25 | $47.1M | $80.8M | ||
| Q2 25 | $72.7M | $101.4M | ||
| Q1 25 | $53.1M | $108.3M | ||
| Q4 24 | $71.3M | $105.5M | ||
| Q3 24 | $134.9M | $96.0M | ||
| Q2 24 | $84.3M | $105.6M | ||
| Q1 24 | $190.1M | $115.3M |
总债务ARQTRGR
| Q4 25 | $109.0M | — | ||
| Q3 25 | $108.5M | — | ||
| Q2 25 | $108.0M | — | ||
| Q1 25 | $107.6M | — | ||
| Q4 24 | $107.2M | — | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
股东权益ARQTRGR
| Q4 25 | $189.5M | $283.8M | ||
| Q3 25 | $158.1M | $279.6M | ||
| Q2 25 | $139.0M | $289.3M | ||
| Q1 25 | $142.7M | $321.5M | ||
| Q4 24 | $157.5M | $319.6M | ||
| Q3 24 | $156.6M | $314.9M | ||
| Q2 24 | $186.4M | $321.5M | ||
| Q1 24 | $224.9M | $332.0M |
总资产ARQTRGR
| Q4 25 | $433.0M | $342.0M | ||
| Q3 25 | $371.0M | $342.3M | ||
| Q2 25 | $352.4M | $349.5M | ||
| Q1 25 | $344.1M | $379.0M | ||
| Q4 24 | $348.9M | $384.0M | ||
| Q3 24 | $437.4M | $373.5M | ||
| Q2 24 | $444.8M | $376.7M | ||
| Q1 24 | $478.5M | $385.0M |
负债/权益比ARQTRGR
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | — | $12.3M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $38.5M |
8季度趋势，按日历期对齐
经营现金流ARQTRGR
| Q4 25 | $26.2M | $15.5M | ||
| Q3 25 | $-1.8M | $12.9M | ||
| Q2 25 | $324.0K | $14.7M | ||
| Q1 25 | $-30.4M | $11.1M | ||
| Q4 24 | $-748.0K | $20.0M | ||
| Q3 24 | $-34.7M | $9.4M | ||
| Q2 24 | $-45.1M | $18.7M | ||
| Q1 24 | $-31.6M | $7.3M |
自由现金流ARQTRGR
| Q4 25 | — | $12.3M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | $246.0K | $9.1M | ||
| Q1 25 | $-31.0M | $10.0M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | $-34.8M | $2.6M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.6M |
自由现金流率ARQTRGR
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | 0.3% | 6.9% | ||
| Q1 25 | -47.1% | 7.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | -77.8% | 2.1% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | — | 4.1% |
资本支出强度ARQTRGR
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.1% | 4.2% | ||
| Q1 25 | 0.9% | 0.8% | ||
| Q4 24 | 0.0% | 2.5% | ||
| Q3 24 | 0.3% | 5.5% | ||
| Q2 24 | 0.0% | 6.6% | ||
| Q1 24 | 0.0% | 1.3% |
现金转化率ARQTRGR
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARQT
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
